SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neotherapuetics possibly has a breakthrough drug - NEOT -- Ignore unavailable to you. Want to Upgrade?

To: Marty who wrote (78)2/24/2000 10:46:00 AM
From: tuck  Read Replies (1) | Respond to of 204
 
Marty,

I could be wrong, probably am, but one reason I was first looking at NEOT a year or so ago, was that CBOE listed options for it. Maybe I'm getting senile already and need some Neotrofin. It certainly doesn't now. Another example of this, more understandable, is NZYM. It no longer has options because of an extended stay below 5. NEOT had such low volume that maybe the option market makers gave up on it.

Whatever. Definitely moot now.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News